Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | — |
Patient went on a trip during Vivotif schedule and did not take all four doses correctly; Case reference number US-BN-2025-001277 is a spontaneous case initially received from a nurse via Bavarian Nordic (reference number: BN_2025_00168) on 10-Jul-2025 and concerns a patient of unknown age and gender. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient took unspecified number of doses of Vivotif (batch number: unknown), at an unknown dose, route or site of administration for unknown indication. As reported, the patient went on a trip and did not take all four doses correctly (explicitly coded as: 'inappropriate schedule of product administration'). At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif. Additional reference information received from Bavarian Nordic on 17-Jul-2025 included: country of occurrence.; Reporter's Comments: This case concerns a patient of unknown age and gender, who received unspecified number of doses of Vivotif vaccine, for an unknown indication. As reported, patient went on a trip and did not take all four doses correctly, which is considered as 'inappropriate schedule of product administered'. Inappropriate schedule of product administered is considered as listed per company convention. At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif. The patient's relevant medical history and concomitant medication details were not provided. Inappropriate schedule of product administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: This case concerns a patient of unknown age and gender, who received unspecified number of doses of Vivotif vaccine, for an unknown indication. As reported, patient went on a trip and did not take all four doses correctly, which is considered as 'inappropriate schedule of product administered'. Inappropriate schedule of product administered is considered as listed per company convention. At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif. The patient's relevant medical history and concomitant medication details were not provided. Inappropriate schedule of product administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.